David Klimstra is the Chief Medical Officer at Paige and was previously the Chair of Pathology at Memorial Sloan Kettering Cancer Center. Paige is a medical company offering the first FDA cleared artificial intelligence platform to assist with the diagnosis of prostate cancer. Dr. Klimstra joins the show to discuss building a robust digital pathology program at MSKCC and the transition from academia to industry. Furthermore, he offers insights into what the first FDA clearance for an AI product means to the industry and the overall breadth of AI applications in pathology.
A forum to engage with the hosts and other listeners has been launched on the DPA website www.digitalpathologyassociation.org. DPA members may login to the DPA Collaborate hub (under the Resources tab) and join the Beyond The Scope community. All listeners are encouraged to use this forum to suggest future topics and guests, submit questions and corrections, and provide general feedback.